Migraine with Aura Characterized as Independent Risk Factor for Atrial Fibrillation
September 22, 2022

Adults with migraine with aura were found at significantly greater risk for AF and those younger than age 55 years were particularly vulnerable, write Mayo Clinic investigators.

Intervention Reduces Aspirin Use in Patients with AF, VTE Taking Warfarin, Improves Outcomes
September 21, 2022

An aspirin deprescribing intervention at anticoagulation clinics led to a 50% reduction in use among patients with AF, VTE prescribed warfarin.

Urban Areas in US are Associated with Lower Rates of Hypertension Medication Adherence, New Study Finds
September 13, 2022

AHA Hypertension 2022: New research showed that hypertension medication adherence was nearly 76% in large urban areas and increased as population density decreased.

Abelacimab Receives Fast Track Designation from FDA for Prevention of Stroke, Systemic Embolism in Patients with Atrial Fibrillation
September 09, 2022

Abelacimab is a dual-acting, fully human monoclonal antibody that selectively targets both factor XI and factor XIa with high affinity.

DASH Diet May Prevent Nearly 27 000 US CVD Events in Patients with Stage 1 Hypertension, According to Simulation Study
September 08, 2022

AHA Hypertension 2022: Adoption of the DASH diet was found to prevent an estimated 16 000 CVD events among men and 11 000 among women with untreated stage 1 HTN.

Education on Use of ABPM Data Needed in Primary Care to Avoid Misdiagnosis of Hypertension
September 08, 2022

AHA Hypertension 2022. Half of patients with newly elevated BP had white coat HTN yet some were diagnosed with HTN at next primary care visit, new study finds.

COVID-19 mRNA Vaccines Found Safe in Patients with Heart Failure in Real-world Study
September 07, 2022

ESC 2022: SARS-CoV-2 mRNA vaccines were not associated with an increased risk of worsening heart failure, venous thromboembolism, or myocarditis in a large Danish real-world study.

Hypertension Awareness and Control Improved with Better Access to Primary Care, New Study Finds
September 06, 2022

Regardless of where individuals live, they may benefit from blood pressure control programs that increase access to primary health care, study authors suggest.

Specific Blood Pressure Thresholds Not Needed When Selecting Patients with T2D for Antihypertensive Treatment, Suggests New Research
August 30, 2022

Blood pressure-lowering therapy reduced the risk of major CV events in persons with and without type 2 diabetes, according to an individual participant-level data meta-analysis.

White Coat & Masked Hypertension: A Primary Care Guideline Topline
August 30, 2022

White coat and masked hypertension can be elusive and dangerous. Click through a topline look at recommendations from the 2017 ACC/AHA hypertension guidelines.